Cagrilintide vs Pramlintide | Research Comparison | QSC

Cagrilintide vs Pramlintide

Mechanism, Phase 2 data, and research applications compared

Shop Both at QSC →

Factor Cagrilintide Pramlintide
Receptor AMY1R (amylin-1) Amylin analogue (approved)
Best Trial Result −15.6% CagriSema (32wks) ~3-4% weight loss
At QSC ✓ In Stock ✓ In Stock
Research analysis: Cagrilintide is next-gen AMY1R agonist vs pramlintide — longer half-life, once-weekly, higher efficacy.
Research Use Only. All QSC products for in vitro laboratory research only.
Peptides
Orals
Oils
Search
Contact